{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:14:09Z","timestamp":1790374449103,"version":"4.1.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Adolescents and youth living with HIV have poorer antiretroviral treatment (ART) adherence and viral suppression outcomes than all other age groups. Effective interventions promoting adherence are urgently needed. We reviewed and synthesized recent literature on interventions to improve ART adherence among this vulnerable population. We focus on studies conducted in low- and middle-income countries (LMIC) where the adolescent and youth HIV burden is greatest. Articles published between September 2015 and January 2019 were identified through PubMed. Inclusion criteria were: [1] included participants ages 10\u201324\u00a0years; [2] assessed the efficacy of an intervention to improve ART adherence; [3] reported an ART adherence measurement or viral load; [4] conducted in a LMIC. Articles were reviewed for study population characteristics, intervention type, study design, outcomes measured, and intervention effect. Strength of each study\u2019s evidence was evaluated according to an adapted World Health Organization GRADE system. Articles meeting all inclusion criteria except being conducted in an LMIC were reviewed for results and potential transportability to a LMIC setting. Of 108 articles identified, 7 met criteria for inclusion. Three evaluated patient-level interventions and four evaluated health services interventions. Of the patient-level interventions, two were experimental designs and one was a retrospective cohort study. None of these interventions improved ART adherence or viral suppression. Of the four health services interventions, two targeted stable patients and reduced the amount of time spent in the clinic or grouped patients together for bi-monthly meetings, and two targeted patients newly diagnosed with HIV or not yet deemed clinically stable and augmented clinical care with home-based case-management. The two studies targeting stable patients used retrospective cohort designs and found that adolescents and youth were less likely to maintain viral suppression than children or adults. The two studies targeting patients not yet deemed clinically stable included one experimental and one retrospective cohort design and showed improved ART adherence and viral suppression outcomes. ART adherence and viral suppression outcomes remain a major challenge among adolescents and youth. Intensive home-based case management models of care hold promise for improving outcomes in this population and warrant further research.<\/jats:p>","DOI":"10.1007\/s10461-020-02822-4","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T15:02:43Z","timestamp":1583766163000},"page":"2797-2810","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Interventions to Improve Antiretroviral Therapy Adherence Among Adolescents and Youth in Low- and Middle-Income Countries: A Systematic Review 2015\u20132019"],"prefix":"10.1007","volume":"24","author":[{"given":"Lindsey K.","family":"Reif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine J.","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Arpadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Batya","family":"Elul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret L.","family":"McNairy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,9]]},"reference":[{"key":"2822_CR1","doi-asserted-by":"crossref","first-page":"20049","DOI":"10.7448\/IAS.18.1.20049","volume":"18","author":"OA Adejumo","year":"2015","unstructured":"Adejumo OA, Malee KM, Ryscavage P, Hunter SJ, Taiwo BO. Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review. J Int AIDS Soc. 2015;18:20049.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"2822_CR2","doi-asserted-by":"crossref","first-page":"20683","DOI":"10.7448\/IAS.19.1.20683","volume":"19","author":"M Salou","year":"2016","unstructured":"Salou M, Dagnra AY, Butel C, et al. High rates of virological failure and drug resistance in perinatally HIV-1-infected children and adolescents receiving lifelong antiretroviral therapy in routine clinics in Togo. J Int AIDS Soc. 2016;19(1):20683.","journal-title":"J Int AIDS Soc."},{"issue":"5","key":"2822_CR3","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S1054-139X(99)00052-X","volume":"25","author":"ME Belzer","year":"1999","unstructured":"Belzer ME, Fuchs DN, Luftman GS, Tucker DJ. Antiretroviral adherence issues among HIV-positive adolescents and young adults. J Adolesc Health. 1999;25(5):316\u20139.","journal-title":"J Adolesc Health"},{"issue":"4","key":"2822_CR4","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/QAD.0000000000000054","volume":"28","author":"MR Lamb","year":"2014","unstructured":"Lamb MR, Fayorsey R, Nuwagaba-Biribonwoha H, et al. High attrition before and after ART initiation among youth (15\u201324 years of age) enrolled in HIV care. AIDS. 2014;28(4):559\u201368.","journal-title":"AIDS"},{"issue":"1","key":"2822_CR5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/COH.0b013e328333ad61","volume":"5","author":"JB Nachega","year":"2010","unstructured":"Nachega JB, Mills EJ, Schechter M. Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities. Current Opinion in HIV and AIDS. 2010;5(1):70\u20137.","journal-title":"Current Opinion in HIV and AIDS"},{"issue":"1","key":"2822_CR6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-133-1-200007040-00004","volume":"133","author":"DL Paterson","year":"2000","unstructured":"Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21\u201330.","journal-title":"Ann Intern Med"},{"key":"2822_CR7","unstructured":"UNICEF. Children and AIDS. Statistical Update. New York: UNICEF. 2015. Available from https:\/\/data.unicef.org\/wp-content\/uploads\/2015\/12\/2015-Children-Adolescents-and-AIDS-Statistical-Update-Executive-Summary_244.pdf. Accessed 15 Aug 2019."},{"key":"2822_CR8","unstructured":"UNICEF. Adolescent HIV Prevention. UNICEF Data. 2018. Available from https:\/\/data.unicef.org\/topic\/hivaids\/adolescents-young-people\/. Accessed 15 Aug 2019."},{"key":"2822_CR9","first-page":"Cd000011","volume":"2","author":"RB Haynes","year":"2008","unstructured":"Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;2:Cd000011.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2822_CR10","first-page":"91","volume":"35","author":"RB Haynes","year":"1980","unstructured":"Haynes RB, Sackett DL, Taylor DW. How to detect and manage low patient compliance in chronic illness. Geriatrics. 1980;35(1):91.","journal-title":"Geriatrics"},{"key":"2822_CR11","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13643-016-0278-5","volume":"5","author":"EC Morrissey","year":"2016","unstructured":"Morrissey EC, Durand H, Nieuwlaat R, et al. Effectiveness and content analysis of interventions to enhance medication adherence in hypertension: a systematic review and meta-analysis protocol. Syst Rev. 2016;5:96.","journal-title":"Syst Rev"},{"key":"2822_CR12","first-page":"Cd000011","volume":"11","author":"R Nieuwlaat","year":"2014","unstructured":"Nieuwlaat R, Wilczynski N, Navarro T, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;11:Cd000011.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2822_CR13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0738-3991(01)00219-1","volume":"46","author":"L Fogarty","year":"2002","unstructured":"Fogarty L, Roter D, Larson S, Burke J, Gillespie J, Levy R. Patient adherence to HIV medication regimens: a review of published and abstract reports. Patient Educ Couns. 2002;46(2):93\u2013108.","journal-title":"Patient Educ Couns"},{"issue":"5","key":"2822_CR14","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1176\/appi.psy.45.5.394","volume":"45","author":"A Ammassari","year":"2004","unstructured":"Ammassari A, Antinori A, Aloisi MS, et al. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics. 2004;45(5):394\u2013402.","journal-title":"Psychosomatics"},{"issue":"Suppl 3","key":"2822_CR15","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1097\/00126334-200212153-00007","volume":"31","author":"A Ammassari","year":"2002","unstructured":"Ammassari A, Trotta MP, Murri R, et al. Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr. 2002;31(Suppl 3):S123\u2013S127127.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"2822_CR16","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1212\/WNL.61.5.723","volume":"61","author":"AA Ammassari","year":"2003","unstructured":"Ammassari AA, Starace F, Aloisi MS, et al. Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology. 2003;61(5):723\u20134.","journal-title":"Neurology"},{"key":"2822_CR17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12889-016-2854-y","volume":"16","author":"A Abubakar","year":"2016","unstructured":"Abubakar A, Van de Vijver FJ, Fischer R, et al. 'Everyone has a secret they keep close to their hearts\u2019: challenges faced by adolescents living with HIV infection at the Kenyan coast. BMC Public Health. 2016;16:197.","journal-title":"BMC Public Health"},{"issue":"3","key":"2822_CR18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/scan\/nsl024","volume":"1","author":"S Choudhury","year":"2006","unstructured":"Choudhury S, Blakemore SJ, Charman T. Social cognitive development during adolescence. Soc Cognit Affect Neurosci. 2006;1(3):165\u201374.","journal-title":"Soc Cognit Affect Neurosci"},{"key":"2822_CR19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.bandc.2013.09.008","volume":"83","author":"T Willoughby","year":"2013","unstructured":"Willoughby T, Good M, Adachi PJC, Hamza C, Tavernier R. Examining the link between adolescent brain development and risk taking from a social-developmental perspective. Brain Cogn. 2013;83:315\u201323.","journal-title":"Brain Cogn"},{"issue":"1","key":"2822_CR20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12978-018-0460-4","volume":"15","author":"I Yakubu","year":"2018","unstructured":"Yakubu I, Salisu WJ. Determinants of adolescent pregnancy in sub-Saharan Africa: a systematic review. Reprod Health. 2018;15(1):15.","journal-title":"Reprod Health"},{"issue":"4","key":"2822_CR21","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.pedhc.2011.02.014","volume":"26","author":"MR Tanney","year":"2012","unstructured":"Tanney MR, Naar-King S, MacDonnel K. Depression and stigma in high-risk youth living with HIV: a multi-site study. J Pediatr Health Care. 2012;26(4):300\u20135.","journal-title":"J Pediatr Health Care"},{"issue":"7","key":"2822_CR22","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/09540121.2015.1131966","volume":"28","author":"M Mutumba","year":"2016","unstructured":"Mutumba M, Musiime V, Lepkwoski JM, et al. Examining the relationship between psychological distress and adherence to anti-retroviral therapy among Ugandan adolescents living with HIV. AIDS Care. 2016;28(7):807\u201315.","journal-title":"AIDS Care"},{"issue":"8","key":"2822_CR23","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1080\/09540121003623693","volume":"22","author":"I Petersen","year":"2010","unstructured":"Petersen I, Bhana A, Myeza N, et al. Psychosocial challenges and protective influences for socio-emotional coping of HIV+ adolescents in South Africa: a qualitative investigation. AIDS Care. 2010;22(8):970\u20138.","journal-title":"AIDS Care"},{"key":"2822_CR24","doi-asserted-by":"crossref","first-page":"18603","DOI":"10.7448\/IAS.16.1.18603","volume":"16","author":"B Laughton","year":"2013","unstructured":"Laughton B, Cornell M, Boivin M, Van Rie A. Neurodevelopment in perinatally HIV-infected children: a concern for adolescence. J Int AIDS Soc. 2013;16:18603.","journal-title":"J Int AIDS Soc"},{"issue":"6","key":"2822_CR25","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/INF.0b013e318253844b","volume":"31","author":"R Smith","year":"2012","unstructured":"Smith R, Chernoff M, Williams PL, et al. Impact of HIV severity on cognitive and adaptive functioning during childhood and adolescence. Pediatr Infect Dis J. 2012;31(6):592\u20138.","journal-title":"Pediatr Infect Dis J"},{"key":"2822_CR26","first-page":"1","volume":"29","author":"SC Kalichman","year":"2016","unstructured":"Kalichman SC, Kalichman MO, Cherry C. Forget about forgetting: structural barriers and severe non-adherence to antiretroviral therapy. AIDS Care. 2016;29:1\u20135.","journal-title":"AIDS Care"},{"issue":"4","key":"2822_CR27","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s11096-014-9930-0","volume":"36","author":"I Krummenacher","year":"2014","unstructured":"Krummenacher I, Spencer B, Du Pasquier S, Bugnon O, Cavassini M, Schneider MP. Qualitative analysis of barriers and facilitators encountered by HIV patients in an ART adherence programme. Int J Clin Pharm. 2014;36(4):716\u201324.","journal-title":"Int J Clin Pharm."},{"issue":"11","key":"2822_CR28","doi-asserted-by":"crossref","first-page":"e1002183","DOI":"10.1371\/journal.pmed.1002183","volume":"13","author":"Z Shubber","year":"2016","unstructured":"Shubber Z, Mills EJ, Nachega JB, et al. Patient-reported barriers to adherence to antiretroviral therapy: a systematic review and meta-analysis. PLoS Med. 2016;13(11):e1002183.","journal-title":"PLoS Med"},{"key":"2822_CR29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2147\/PPA.S96691","volume":"10","author":"DN Ankrah","year":"2016","unstructured":"Ankrah DN, Koster ES, Mantel-Teeuwisse AK, Arhinful DK, Agyepong IA, Lartey M. Facilitators and barriers to antiretroviral therapy adherence among adolescents in Ghana. Patient Prefer Adher. 2016;10:329\u201337.","journal-title":"Patient Prefer Adher"},{"issue":"7","key":"2822_CR30","doi-asserted-by":"crossref","first-page":"142","DOI":"10.11124\/01938924-201513070-00013","volume":"13","author":"M Soboka","year":"2015","unstructured":"Soboka M, Feyissa GT. The effectiveness of counseling, material support and\/or nutritional supplementation on improving adherence to anti-retroviral therapy and clinical outcomes among HIV patients: a systematic review of quantitative evidence protocol. JBI Database Syst Rev Implement Rep. 2015;13(7):142\u201352.","journal-title":"JBI Database Syst Rev Implement Rep"},{"issue":"3","key":"2822_CR31","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/tmi.12656","volume":"21","author":"RA Ferrand","year":"2016","unstructured":"Ferrand RA, Briggs D, Ferguson J, et al. Viral suppression in adolescents on antiretroviral treatment: review of the literature and critical appraisal of methodological challenges. Trop Med Int Health. 2016;21(3):325\u201333.","journal-title":"Trop Med Int Health"},{"issue":"4","key":"2822_CR32","doi-asserted-by":"crossref","first-page":"e60073","DOI":"10.1371\/journal.pone.0060073","volume":"8","author":"PR Mutwa","year":"2013","unstructured":"Mutwa PR, Van Nuil JI, Asiimwe-Kateera B, et al. Living situation affects adherence to combination antiretroviral therapy in HIV-infected adolescents in Rwanda: a qualitative study. PLoS ONE. 2013;8(4):e60073.","journal-title":"PLoS ONE"},{"issue":"10","key":"2822_CR33","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1080\/09540121.2013.764391","volume":"25","author":"PM Musumari","year":"2013","unstructured":"Musumari PM, Feldman MD, Techasrivichien T, Wouters E, Ono-Kihara M, Kihara M. \u201cIf I have nothing to eat, I get angry and push the pills bottle away from me\u201d: a qualitative study of patient determinants of adherence to antiretroviral therapy in the Democratic Republic of Congo. AIDS Care. 2013;25(10):1271\u20137.","journal-title":"AIDS Care"},{"issue":"3","key":"2822_CR34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1089\/apc.2008.0162","volume":"23","author":"BJ Rudy","year":"2009","unstructured":"Rudy BJ, Murphy DA, Harris DR, Muenz L, Ellen J. Patient-related risks for nonadherence to antiretroviral therapy among HIV-infected youth in the United States: a study of prevalence and interactions. AIDS Patient Care and STDs. 2009;23(3):185\u201394.","journal-title":"AIDS Patient Care and STDs"},{"key":"2822_CR35","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1007\/s10461-016-1508-5","volume":"21","author":"KD Hermetet-Lindsay","year":"2016","unstructured":"Hermetet-Lindsay KD, Correia KF, Williams PL, et al. Contributions of disease severity, psychosocial factors, and cognition to behavioral functioning in US youth perinatally exposed to HIV. AIDS Behav. 2016;21:2703\u201315.","journal-title":"AIDS Behav"},{"issue":"7","key":"2822_CR36","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1080\/09540121.2015.1024098","volume":"27","author":"GT Daigle","year":"2015","unstructured":"Daigle GT, Jolly PE, Chamot EA, et al. System-level factors as predictors of adherence to clinical appointment schedules in antiretroviral therapy in Cambodia. AIDS Care. 2015;27(7):836\u201343.","journal-title":"AIDS Care"},{"issue":"7","key":"2822_CR37","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/09540121.2015.1011073","volume":"27","author":"C Hudelson","year":"2015","unstructured":"Hudelson C, Cluver L. Factors associated with adherence to antiretroviral therapy among adolescents living with HIV\/AIDS in low- and middle-income countries: a systematic review. AIDS Care. 2015;27(7):805\u201316.","journal-title":"AIDS Care"},{"issue":"3","key":"2822_CR38","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/archpedi.157.3.249","volume":"157","author":"DA Murphy","year":"2003","unstructured":"Murphy DA, Sarr M, Durako SJ, Moscicki AB, Wilson CM, Muenz LR. Barriers to HAART adherence among human immunodeficiency virus-infected adolescents. Arch Pediatr Adolesc Med. 2003;157(3):249\u201355.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"1","key":"2822_CR39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/09540120020018161","volume":"13","author":"DA Murphy","year":"2001","unstructured":"Murphy DA, Wilson CM, Durako SJ, Muenz LR, Belzer M. Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA. AIDS Care. 2001;13(1):27\u201340.","journal-title":"AIDS Care"},{"issue":"5","key":"2822_CR40","doi-asserted-by":"crossref","first-page":"e1244","DOI":"10.1542\/peds.2011-1740","volume":"129","author":"AL Buchanan","year":"2012","unstructured":"Buchanan AL, Montepiedra G, Sirois PA, et al. Barriers to medication adherence in HIV-infected children and youth based on self- and caregiver report. Pediatrics. 2012;129(5):e1244\u2013e12511251.","journal-title":"Pediatrics"},{"issue":"7","key":"2822_CR41","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1080\/09540121.2015.1009362","volume":"27","author":"CW Holtzman","year":"2015","unstructured":"Holtzman CW, Shea JA, Glanz K, et al. Mapping patient-identified barriers and facilitators to retention in HIV care and antiretroviral therapy adherence to Andersen's Behavioral Model. AIDS Care. 2015;27(7):817\u201328.","journal-title":"AIDS Care"},{"issue":"4","key":"2822_CR42","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/QAI.0000000000000977","volume":"72","author":"S Shaw","year":"2016","unstructured":"Shaw S, Amico KR. Antiretroviral therapy adherence enhancing interventions for adolescents and young adults 13\u201324 years of age: a review of the evidence base. J Acquir Immune Defic Syndr. 2016;72(4):387\u201399.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"2822_CR43","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.2196\/jmir.2015","volume":"14","author":"N Dowshen","year":"2012","unstructured":"Dowshen N, Kuhns LM, Johnson A, Holoyda BJ, Garofalo R. Improving adherence to antiretroviral therapy for youth living with HIV\/AIDS: a pilot study using personalized, interactive, daily text message reminders. J Med Internet Res. 2012;14(2):e51.","journal-title":"J Med Internet Res"},{"issue":"4","key":"2822_CR44","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s10461-013-0661-3","volume":"18","author":"ME Belzer","year":"2014","unstructured":"Belzer ME, Naar-King S, Olson J, et al. The use of cell phone support for non-adherent HIV-infected youth and young adults: an initial randomized and controlled intervention trial. AIDS Behav. 2014;18(4):686\u201396.","journal-title":"AIDS Behav"},{"issue":"6","key":"2822_CR45","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/jpepsy\/jss132","volume":"38","author":"S Naar-King","year":"2013","unstructured":"Naar-King S, Outlaw AY, Sarr M, et al. Motivational Enhancement System for Adherence (MESA): pilot randomized trial of a brief computer-delivered prevention intervention for youth initiating antiretroviral treatment. J Pediatr Psychol. 2013;38(6):638\u201348.","journal-title":"J Pediatr Psychol"},{"key":"2822_CR46","unstructured":"The World by Income and Region. The World Bank. 2017. Available from: https:\/\/datatopics.worldbank.org\/world-development-indicators\/the-world-by-income-and-region.html. Accessed 15 Aug 2019."},{"key":"2822_CR47","doi-asserted-by":"crossref","unstructured":"Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart L, PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015 2;349:g7647.","DOI":"10.1136\/bmj.g7647"},{"key":"2822_CR48","unstructured":"Antiretroviral Therapy for HIV Infection in Infants and Children: Towards Universal Access: Recommendations for a Public Health Approach. Geneva: World Health Organization; 2010. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK138585\/. Accessed 15 Aug 2019."},{"key":"2822_CR49","unstructured":"The Global Fund. A Toolkit for Health Facilities: Differentiated Care for HIV and Tuberculosis. Geneva, Switzerland; 2015. Available from: https:\/\/www.theglobalfund.org\/media\/2569\/core_differentiatedcare_toolkit_en.pdf. Accessed 15 Aug 2019."},{"issue":"1","key":"2822_CR50","doi-asserted-by":"crossref","first-page":"21484","DOI":"10.7448\/IAS.19.1.21484","volume":"19","author":"A Grimsrud","year":"2016","unstructured":"Grimsrud A, Bygrave H, Doherty M, et al. Reimagining HIV service delivery: the role of differentiated care from prevention to suppression. J Int AIDS Soc. 2016;19(1):21484.","journal-title":"J Int AIDS Soc."},{"issue":"12","key":"2822_CR51","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.2105\/AJPH.2017.304089","volume":"107","author":"S Linnemayr","year":"2017","unstructured":"Linnemayr S, Huang H, Luoto J, et al. Text Messaging for Improving Antiretroviral Therapy Adherence: No Effects After 1 Year in a Randomized Controlled Trial Among Adolescents and Young Adults. Am J Public Health. 2017;107(12):1944\u201350.","journal-title":"Am J Public Health"},{"issue":"11","key":"2822_CR52","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1007\/s10461-018-2173-7","volume":"22","author":"LG Bermudez","year":"2018","unstructured":"Bermudez LG, Ssewamala FM, Neilands TB, et al. Does Economic Strengthening improve viral suppression among adolescents living with HIV? results from a cluster randomized trial in Uganda. AIDS Behav. 2018;22(11):3763\u201372.","journal-title":"AIDS Behav"},{"issue":"1","key":"2822_CR53","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1186\/s12889-018-5964-x","volume":"18","author":"E Nasuuna","year":"2018","unstructured":"Nasuuna E, Kigozi J, Babirye L, Muganzi A, Sewankambo NK, Nakanjako D. Low HIV viral suppression rates following the intensive adherence counseling (IAC) program for children and adolescents with viral failure in public health facilities in Uganda. BMC Public Health. 2018;18(1):1048.","journal-title":"BMC Public Health"},{"issue":"Suppl 2","key":"2822_CR54","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1097\/QAI.0000000000001730","volume":"78","author":"M Kim","year":"2018","unstructured":"Kim M, Wanless RS, Caviness C, et al. Multi-month prescription of antiretroviral therapy amongst children and adolescents: experiences from the Baylor International Pediatric AIDS initiative (BIPAI) in six African countries. J Acquir Immune Defic Syndr. 2018;78(Suppl 2):S71\u201380.","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"1","key":"2822_CR55","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1097\/QAI.0000000000000863","volume":"71","author":"A Grimsrud","year":"2016","unstructured":"Grimsrud A, Lesosky M, Kalombo C, Bekker LG, Myer L. Implementation and operational research: community-based adherence clubs for the management of stable antiretroviral therapy patients in Cape Town, South Africa: a cohort study. J Acquir Immune Defic Syndr. 2016;71(1):e16\u201323.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl","key":"2822_CR56","first-page":"1","volume":"21","author":"G Fatti","year":"2018","unstructured":"Fatti G, Jackson D, Goga AE, et al. The effectiveness and cost-effectiveness of community-based support for adolescents receiving antiretroviral treatment: an operational research study in South Africa. J Int AIDS Soc. 2018;21(Suppl):1.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"2822_CR57","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12889-019-6447-4","volume":"19","author":"N Willis","year":"2019","unstructured":"Willis N, Milanzi A, Mawodzeke M, et al. Effectiveness of community adolescent treatment supporters (CATS) interventions in improving linkage and retention in care, adherence to ART and psychosocial well-being: a randomised trial among adolescents living with HIV in rural Zimbabwe. BMC Public Health. 2019;19(1):117.","journal-title":"BMC Public Health"},{"issue":"1","key":"2822_CR58","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/apc.2018.0138","volume":"33","author":"MJ Mimiaga","year":"2019","unstructured":"Mimiaga MJ, Bogart LM, Thurston IB, et al. positive strategies to enhance problem-solving skills (STEPS): a pilot randomized, controlled trial of a multicomponent, technology-enhanced, customizable antiretroviral adherence intervention for HIV-infected adolescents and young adults. AIDS Patient Care and STDs. 2019;33(1):21\u20134.","journal-title":"AIDS Patient Care and STDs"},{"issue":"8","key":"2822_CR59","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1007\/s10461-018-2034-4","volume":"22","author":"SG Hosek","year":"2018","unstructured":"Hosek SG, Harper GW, Lemos D, et al. Project ACCEPT: Evaluation of a group-based intervention to improve engagement in care for youth newly diagnosed with HIV. AIDS Behav. 2018;22(8):2650\u201361.","journal-title":"AIDS Behav"},{"issue":"4","key":"2822_CR60","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/INF.0000000000001807","volume":"37","author":"E Stankievich","year":"2018","unstructured":"Stankievich E, Malanca A, Foradori I, Ivalo S, Losso M. Utility of mobile communication devices as a tool to improve adherence to antiretroviral treatment in HIV-infected children and young adults in Argentina. Pediatr Infect Dis J. 2018;37(4):345\u20138.","journal-title":"Pediatr Infect Dis J"},{"key":"2822_CR61","first-page":"1","volume":"30","author":"L Whiteley","year":"2019","unstructured":"Whiteley L, Brown LK, Mena L, Craker L, Arnold T. Enhancing health among youth living with HIV using an iPhone game. AIDS Care. 2019;30:1\u201313.","journal-title":"AIDS Care"},{"issue":"12","key":"2822_CR62","doi-asserted-by":"crossref","first-page":"e11183","DOI":"10.2196\/11183","volume":"7","author":"ME Belzer","year":"2018","unstructured":"Belzer ME, MacDonell KK, Ghosh S, et al. Adaptive antiretroviral therapy adherence interventions for youth living with HIV through text message and cell phone support with and without incentives: protocol for a sequential multiple assignment randomized trial (SMART). JMIR Res Protoc. 2018;7(12):e11183.","journal-title":"JMIR Res Protoc"},{"issue":"1","key":"2822_CR63","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1186\/s13063-017-2198-7","volume":"18","author":"W Mavhu","year":"2017","unstructured":"Mavhu W, Willis N, Mufuka J, et al. Evaluating a multi-component, community-based program to improve adherence and retention in care among adolescents living with HIV in Zimbabwe: study protocol for a cluster randomized controlled trial. Trials. 2017;18(1):478.","journal-title":"Trials"},{"issue":"1","key":"2822_CR64","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1186\/s12889-018-5815-9","volume":"18","author":"MJ Mimiaga","year":"2018","unstructured":"Mimiaga MJ, Kuhns LM, Biello KB, et al. Positive STEPS - a randomized controlled efficacy trial of an adaptive intervention for strengthening adherence to antiretroviral HIV treatment among youth: study protocol. BMC Public Health. 2018;18(1):867.","journal-title":"BMC Public Health"},{"issue":"1","key":"2822_CR65","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1186\/s13063-018-3095-4","volume":"19","author":"OI Ekwunife","year":"2018","unstructured":"Ekwunife OI, Anetoh MU, Kalu SO, Ele PU, Eleje GU. Conditional economic incentives and motivational interviewing to improve adolescents' retention in HIV care and adherence to antiretroviral therapy in Southeast Nigeria: study protocol for a cluster randomised trial. Trials. 2018;19(1):710.","journal-title":"Trials"},{"issue":"11","key":"2822_CR66","doi-asserted-by":"crossref","first-page":"e1002433","DOI":"10.1371\/journal.pmed.1002433","volume":"14","author":"B Elul","year":"2017","unstructured":"Elul B, Lamb MR, Lahuerta M, et al. A combination intervention strategy to improve linkage to and retention in HIV care following diagnosis in Mozambique: A cluster-randomized study. PLoS Med. 2017;14(11):e1002433.","journal-title":"PLoS Med"},{"issue":"11","key":"2822_CR67","doi-asserted-by":"crossref","first-page":"e1002420","DOI":"10.1371\/journal.pmed.1002420","volume":"14","author":"ML McNairy","year":"2017","unstructured":"McNairy ML, Lamb MR, Gachuhi AB, et al. Effectiveness of a combination strategy for linkage and retention in adult HIV care in Swaziland: The Link4Health cluster randomized trial. PLoS Med. 2017;14(11):e1002420.","journal-title":"PLoS Med"},{"issue":"8","key":"2822_CR68","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1001\/archpedi.159.8.764","volume":"159","author":"DA Murphy","year":"2005","unstructured":"Murphy DA, Belzer M, Durako SJ, Sarr M, Wilson CM, Muenz LR. Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus. Arch Pediatr Adolesc Med. 2005;159(8):764\u201370.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2822_CR69","unstructured":"Frieson Bonaparte K, Graves C, Farber, E, Gillespie S, Hussen S, Thomas-Seaton L, Chakraborty R, Camacho-Gonzalez A. Metropolitan Atlanta community adolescent rapid testing initiative: the impact of motivational interviewing and intensive case management on the psychosocial and clinical care outcomes of adolescents and young adults with HIV. Psychotherapy (Chic). 2019; pii: 2019\u201362569\u2013001."},{"issue":"9","key":"2822_CR70","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1080\/09540121.2015.1028882","volume":"27","author":"MR Broaddus","year":"2015","unstructured":"Broaddus MR, Hanna CR, Schumann C, Meier A. \"She makes me feel that I'm not alone\": linkage to Care Specialists provide social support to people living with HIV. AIDS Care. 2015;27(9):1104\u20137.","journal-title":"AIDS Care"},{"issue":"2","key":"2822_CR71","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/187152611795589663","volume":"11","author":"JB Nachega","year":"2011","unstructured":"Nachega JB, Marconi VC, van Zyl GU, et al. HIV treatment adherence, drug resistance, virologic failure: evolving concepts. Infect Disord Drug Targets. 2011;11(2):167\u201374.","journal-title":"Infect Disord Drug Targets"},{"issue":"3","key":"2822_CR72","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/14656566.2018.1559299","volume":"20","author":"V Giacomet","year":"2019","unstructured":"Giacomet V, Cossu MV, Capetti AF, Zuccotti G, Rizzardini G. An evaluation of elvitegravir plus cobicistat plus tenofovir alafenamide plus emtricitabine as a single-tablet regimen for the treatment of HIV in children and adolescents. Expert Opin Pharmacother. 2019;20(3):269\u201376.","journal-title":"Expert Opin Pharmacother"},{"issue":"19","key":"2822_CR73","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJMoa1215541","volume":"369","author":"SL Walmsley","year":"2013","unstructured":"Walmsley SL, Antela A, Clumeck N, et al. Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection. N Engl J Med. 2013;369(19):1807\u201318.","journal-title":"N Engl J Med"},{"issue":"1","key":"2822_CR74","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12978-016-0276-z","volume":"14","author":"NB Ippoliti","year":"2017","unstructured":"Ippoliti NB, L'Engle K. Meet us on the phone: mobile phone programs for adolescent sexual and reproductive health in low-to-middle income countries. Reprod Health. 2017;14(1):11.","journal-title":"Reprod Health"},{"issue":"1","key":"2822_CR75","doi-asserted-by":"crossref","first-page":"e0190487","DOI":"10.1371\/journal.pone.0190487","volume":"13","author":"D Kerrigan","year":"2018","unstructured":"Kerrigan D, Mantsios A, Gorgolas M, et al. Experiences with long acting injectable ART: a qualitative study among PLHIV participating in a Phase II study of cabotegravir + rilpivirine (LATTE-2) in the United States and Spain. PLoS ONE. 2018;13(1):e0190487.","journal-title":"PLoS ONE"},{"issue":"10101","key":"2822_CR76","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0140-6736(17)31917-7","volume":"390","author":"DA Margolis","year":"2017","unstructured":"Margolis DA, Gonzalez-Garcia J, Stellbrink HJ, et al. Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial. Lancet. 2017;390(10101):1499\u2013510.","journal-title":"Lancet"},{"issue":"8","key":"2822_CR77","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1016\/S2352-3018(17)30068-1","volume":"4","author":"M Markowitz","year":"2017","unstructured":"Markowitz M, Frank I, Grant RM, et al. Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial. Lancet HIV. 2017;4(8):e331\u2013e34040.","journal-title":"Lancet HIV"},{"issue":"9","key":"2822_CR78","doi-asserted-by":"crossref","first-page":"e421","DOI":"10.1016\/S2352-3018(16)30054-6","volume":"3","author":"A Turkova","year":"2016","unstructured":"Turkova A, Moore CL, Butler K, et al. Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents, and young adults (BREATHER): a randomised, open-label, non-inferiority, phase 2\/3 trial. Lancet HIV. 2016;3(9):e421\u2013e430430.","journal-title":"Lancet HIV"},{"issue":"2","key":"2822_CR79","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/hiv.12695","volume":"20","author":"DC Griffith","year":"2019","unstructured":"Griffith DC, Farmer C, Gebo KA, et al. Uptake and virological outcomes of single- versus multi-tablet antiretroviral regimens among treatment-naive youth in the HIV Research Network. HIV Med. 2019;20(2):169\u201374.","journal-title":"HIV Med"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-020-02822-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10461-020-02822-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-020-02822-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:45:18Z","timestamp":1615250718000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10461-020-02822-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,9]]},"references-count":79,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["2822"],"URL":"https:\/\/doi.org\/10.1007\/s10461-020-02822-4","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,9]]},"assertion":[{"value":"9 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}